blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3210966

EP3210966 - ALKOXYPHENYLPROPYLAMINES FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.11.2020
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  06.12.2019
FormerGrant of patent is intended
Status updated on  31.07.2019
FormerExamination is in progress
Status updated on  13.04.2018
FormerRequest for examination was made
Status updated on  28.07.2017
Most recent event   Tooltip24.06.2022Lapse of the patent in a contracting state
New state(s): CY, HU, MT, TR
published on 27.07.2022  [2022/30]
Applicant(s)For all designated states
Acucela, Inc.
818 Stewart Street
Suite 1110
Seattle, Washington 98101-3805 / US
[2019/51]
Former [2017/35]For all designated states
Acucela, Inc.
21720-23rd Drive SE, Suite 120
Bothell, WA 98021 / US
Inventor(s)01 / SCOTT, Ian L.
22906 111th Street SE
Monroe, WA 98272 / US
02 / KUKSA, Vladimir A.
417 203rd PI SE
Bothell, WA 98012 / US
03 / ORME, Mark W.
10715 Palatine Avenue North
Seattle, WA 98133 / US
04 / LITTLE, Thomas
18619 NE 100th Court
Redmond, WA 98052 / US
05 / GALL, Anna
20051 170th Avenue NE
Woodinville, WA 98072 / US
06 / HONG, Feng
10042 Main Street, Apt. 301
Bellevue, WA 98004 / US
 [2017/35]
Representative(s)Wytenburg, Wilhelmus Johannes
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[2020/02]
Former [2017/35]Avidity IP
Broers Building
Hauser Forum
21 JJ Thomson Avenue
Cambridge CB3 0FA / GB
Application number, filing date16201976.403.10.2008
[2017/35]
Priority number, dateUS20070977957P05.10.2007         Original published format: US 977957 P
US20080066353P19.02.2008         Original published format: US 66353 P
US20080043127P07.04.2008         Original published format: US 43127 P
US20080051657P08.05.2008         Original published format: US 51657 P
US20080060083P09.06.2008         Original published format: US 60083 P
[2017/35]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3210966
Date:30.08.2017
Language:EN
[2017/35]
Type: B1 Patent specification 
No.:EP3210966
Date:08.01.2020
Language:EN
[2020/02]
Search report(s)(Supplementary) European search report - dispatched on:EP10.07.2017
ClassificationIPC:C07C217/20, C07C217/60, C07C217/72, C07C225/16, C07C229/38, C07C235/08, C07C317/28, C07D277/24, C07D309/06, A61K31/137, A61K31/138, A61K31/145, A61K31/155, A61P27/02
[2017/35]
CPC:
A61K31/137 (EP,GB,US); A61K31/138 (GB); A61K31/155 (GB);
A61K31/165 (EP,GB,US); A61K31/222 (EP,US); A61K31/351 (GB);
A61K31/426 (GB); A61P11/06 (EP); A61P27/00 (EP);
A61P27/02 (EP); A61P27/06 (EP); A61P43/00 (EP);
A61P9/00 (EP); A61P9/10 (EP); C07C211/27 (GB);
C07C211/28 (GB); C07C215/20 (US); C07C217/20 (EP,US);
C07C217/60 (EP,US); C07C217/62 (EP,US); C07C217/64 (EP,US);
C07C217/72 (EP,US); C07C217/84 (US); C07C225/16 (EP,US);
C07C229/38 (EP,US); C07C233/01 (GB); C07C233/18 (EP,US);
C07C235/08 (EP,US); C07C251/86 (EP,US); C07C279/08 (EP,US);
C07C309/06 (US); C07C317/28 (EP,US); C07C323/25 (EP,US);
C07C323/33 (US); C07D277/24 (EP,US); C07D309/06 (EP,US);
C07C2601/02 (EP,US); C07C2601/04 (EP,US); C07C2601/08 (EP,US);
C07C2601/14 (EP,US); C07C2601/18 (EP,US); C07C2602/42 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/35]
TitleGerman:ALKOXY PHENYPROPYLAMINEN ZUR BEHANDLUNG VON ALTERSABHÄNGIGEN MAKULA-DEGENERATION[2017/35]
English:ALKOXYPHENYLPROPYLAMINES FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION[2017/35]
French:ALCOXYPHÉNYLPROPYLAMINES POUR LE TRAITEMENT DE LA DÉGÉNÉRESCENCE MACULAIRE LIÉE À L'ÂGE[2017/35]
Examination procedure02.12.2016Examination requested  [2017/35]
02.12.2016Date on which the examining division has become responsible
27.02.2018Amendment by applicant (claims and/or description)
17.04.2018Despatch of a communication from the examining division (Time limit: M04)
24.08.2018Reply to a communication from the examining division
01.08.2019Communication of intention to grant the patent
29.11.2019Fee for grant paid
29.11.2019Fee for publishing/printing paid
29.11.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP08832784.6  / EP2091955
Opposition(s)09.10.2020No opposition filed within time limit [2020/51]
Fees paidRenewal fee
02.12.2016Renewal fee patent year 03
02.12.2016Renewal fee patent year 04
02.12.2016Renewal fee patent year 05
02.12.2016Renewal fee patent year 06
02.12.2016Renewal fee patent year 07
02.12.2016Renewal fee patent year 08
02.12.2016Renewal fee patent year 09
27.10.2017Renewal fee patent year 10
29.10.2018Renewal fee patent year 11
28.10.2019Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.10.2008
AT08.01.2020
CY08.01.2020
CZ08.01.2020
DK08.01.2020
EE08.01.2020
FI08.01.2020
HR08.01.2020
LT08.01.2020
LV08.01.2020
MC08.01.2020
MT08.01.2020
NL08.01.2020
PL08.01.2020
RO08.01.2020
SE08.01.2020
SI08.01.2020
SK08.01.2020
TR08.01.2020
BG08.04.2020
NO08.04.2020
GR09.04.2020
IS08.05.2020
PT31.05.2020
IE03.10.2020
LU03.10.2020
[2022/27]
Former [2021/46]AT08.01.2020
CZ08.01.2020
DK08.01.2020
EE08.01.2020
FI08.01.2020
HR08.01.2020
LT08.01.2020
LV08.01.2020
MC08.01.2020
NL08.01.2020
PL08.01.2020
RO08.01.2020
SE08.01.2020
SI08.01.2020
SK08.01.2020
BG08.04.2020
NO08.04.2020
GR09.04.2020
IS08.05.2020
PT31.05.2020
IE03.10.2020
LU03.10.2020
Former [2021/31]AT08.01.2020
CZ08.01.2020
DK08.01.2020
EE08.01.2020
FI08.01.2020
HR08.01.2020
LT08.01.2020
LV08.01.2020
MC08.01.2020
NL08.01.2020
PL08.01.2020
RO08.01.2020
SE08.01.2020
SI08.01.2020
SK08.01.2020
BG08.04.2020
NO08.04.2020
GR09.04.2020
IS08.05.2020
PT31.05.2020
LU03.10.2020
Former [2021/11]AT08.01.2020
CZ08.01.2020
DK08.01.2020
EE08.01.2020
FI08.01.2020
HR08.01.2020
LT08.01.2020
LV08.01.2020
NL08.01.2020
PL08.01.2020
RO08.01.2020
SE08.01.2020
SI08.01.2020
SK08.01.2020
BG08.04.2020
NO08.04.2020
GR09.04.2020
IS08.05.2020
PT31.05.2020
Former [2020/50]CZ08.01.2020
DK08.01.2020
EE08.01.2020
FI08.01.2020
HR08.01.2020
LT08.01.2020
LV08.01.2020
NL08.01.2020
RO08.01.2020
SE08.01.2020
SK08.01.2020
BG08.04.2020
NO08.04.2020
GR09.04.2020
IS08.05.2020
PT31.05.2020
Former [2020/49]CZ08.01.2020
DK08.01.2020
FI08.01.2020
HR08.01.2020
LT08.01.2020
LV08.01.2020
NL08.01.2020
RO08.01.2020
SE08.01.2020
SK08.01.2020
BG08.04.2020
NO08.04.2020
GR09.04.2020
IS08.05.2020
PT31.05.2020
Former [2020/47]DK08.01.2020
FI08.01.2020
HR08.01.2020
LT08.01.2020
LV08.01.2020
NL08.01.2020
SE08.01.2020
BG08.04.2020
NO08.04.2020
GR09.04.2020
IS08.05.2020
PT31.05.2020
Former [2020/40]FI08.01.2020
HR08.01.2020
LT08.01.2020
LV08.01.2020
NL08.01.2020
SE08.01.2020
BG08.04.2020
NO08.04.2020
GR09.04.2020
IS08.05.2020
PT31.05.2020
Former [2020/39]FI08.01.2020
HR08.01.2020
LT08.01.2020
LV08.01.2020
NL08.01.2020
SE08.01.2020
BG08.04.2020
NO08.04.2020
GR09.04.2020
PT31.05.2020
Former [2020/38]FI08.01.2020
HR08.01.2020
LT08.01.2020
LV08.01.2020
NL08.01.2020
SE08.01.2020
NO08.04.2020
GR09.04.2020
PT31.05.2020
Former [2020/37]FI08.01.2020
HR08.01.2020
LT08.01.2020
LV08.01.2020
NL08.01.2020
SE08.01.2020
NO08.04.2020
PT31.05.2020
Former [2020/36]FI08.01.2020
LT08.01.2020
NL08.01.2020
NO08.04.2020
PT31.05.2020
Former [2020/35]FI08.01.2020
LT08.01.2020
NL08.01.2020
NO08.04.2020
Former [2020/33]NL08.01.2020
Documents cited:Search[XA]EP0706994  (BRISTOL MYERS SQUIBB CO [US]);
 [A]WO2007038372  (ALCON INC [CH], et al);
by applicantUS4569354
 US5641750
 WO9812303
 US5736516
 WO9929279
 WO0040699
 US6090624
 US6117675
 US6183735
 WO0109327
 WO0142784
 WO0181551
 WO0183714
 US2002009713
 US6406840
 US2003032078
 US2003050283
 US6713300
 US2004116403
 US2004147019
 US2005059148
 US2006069078
 US2007002275
 WO2007US02330
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.